Opening a can of worms in AL progression

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


In this issue of Blood, Palladini et al address one of the most important, yet befuddling questions in immunoglobulin light chain (AL) amyloidosis treatment: what triggers should be used to reinstitute plasma cell clone directed therapy among patients with AL amyloidosis?.

Original languageEnglish (US)
Pages (from-to)475-476
Number of pages2
Issue number5
StatePublished - Feb 1 2018

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Opening a can of worms in AL progression'. Together they form a unique fingerprint.

Cite this